Clinical Trial Update: Clinical Study to Evaluate PRO-169 for Diabetic Macular Edema [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 trial evaluating PRO-169 for diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• PRO-169

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED